PL2320878T3 - Monoterpeny do leczenia chorób dróg oddechowych, w szczególności chorób oskrzelowo-płucnych - Google Patents

Monoterpeny do leczenia chorób dróg oddechowych, w szczególności chorób oskrzelowo-płucnych

Info

Publication number
PL2320878T3
PL2320878T3 PL09777903T PL09777903T PL2320878T3 PL 2320878 T3 PL2320878 T3 PL 2320878T3 PL 09777903 T PL09777903 T PL 09777903T PL 09777903 T PL09777903 T PL 09777903T PL 2320878 T3 PL2320878 T3 PL 2320878T3
Authority
PL
Poland
Prior art keywords
diseases
monoterpenes
treatment
respiratory
particular bronchopulmonary
Prior art date
Application number
PL09777903T
Other languages
English (en)
Inventor
Harald Greve
Original Assignee
Maria Clementine Martin Klosterfrau Vertriebsges Mbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maria Clementine Martin Klosterfrau Vertriebsges Mbh filed Critical Maria Clementine Martin Klosterfrau Vertriebsges Mbh
Publication of PL2320878T3 publication Critical patent/PL2320878T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL09777903T 2008-09-04 2009-08-14 Monoterpeny do leczenia chorób dróg oddechowych, w szczególności chorób oskrzelowo-płucnych PL2320878T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE102008045702 2008-09-04
DE102008047221 2008-09-12
EP09777903.7A EP2320878B1 (de) 2008-09-04 2009-08-14 Monoterpene für die behandlung von atemwegserkrankungen, insbesondere bronchopulmonalen erkrankungen
PCT/EP2009/005931 WO2010025821A1 (de) 2008-09-04 2009-08-14 Monoterpene für die behandlung von atemwegserkrankungen, insbesondere bronchopulmonalen erkrankungen

Publications (1)

Publication Number Publication Date
PL2320878T3 true PL2320878T3 (pl) 2015-07-31

Family

ID=41210874

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09777903T PL2320878T3 (pl) 2008-09-04 2009-08-14 Monoterpeny do leczenia chorób dróg oddechowych, w szczególności chorób oskrzelowo-płucnych

Country Status (7)

Country Link
US (3) US20110257138A1 (pl)
EP (2) EP2647372A1 (pl)
DE (2) DE202009010937U1 (pl)
EA (1) EA022312B1 (pl)
PL (1) PL2320878T3 (pl)
SI (1) SI2320878T1 (pl)
WO (1) WO2010025821A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010022174A1 (de) * 2010-05-12 2011-11-17 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Neue Darreichungsformen für Cineol
EP2723330B1 (de) * 2011-08-19 2015-07-08 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft mbH Vasokonstriktorhaltiges kombinationstherapeutikum
CN105250245A (zh) * 2015-10-15 2016-01-20 北京神州泰洁生物科技有限公司 一种治疗呼吸系统疾病的雾化吸入剂
CN105168178A (zh) * 2015-10-15 2015-12-23 北京神州泰洁生物科技有限公司 一种治疗呼吸系统疾病的软胶囊
RU2650681C1 (ru) * 2017-05-24 2018-04-17 Федеральное Государственное Бюджетное Учреждение Науки Институт Химии Коми Научного Центра Уральского Отделения Российской Академии Наук Способ получения хиральных монотерпеновых сульфинамидов
RU2646959C1 (ru) * 2017-05-31 2018-03-12 Федеральное Государственное Бюджетное Учреждение Науки Институт Химии Коми Научного Центра Уральского Отделения Российской Академии Наук Хиральные монотерпеновые сульфинамиды
DE202021105404U1 (de) * 2020-11-18 2022-02-21 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft mit beschränkter Haftung Neues Therapiekonzept für die Behandlung von Corona-Infektionen, insbesondere COVID-19-Infektionen

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK49688A (da) * 1987-03-20 1988-09-21 Hoffmann La Roche Propiolophenonderivater
CA2140660A1 (en) 1993-06-13 1994-12-22 Uwe R. Juergens Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators
DE4319554C2 (de) 1993-06-13 2002-03-14 Uwe R Juergens Verwendung von Menthol zur peroralen entzündungshemmenden Behandlung von Asthma bronchiale
DE4319556C2 (de) 1993-06-13 1998-12-10 Uwe R Dr Med Juergens Verwendung von 1,8-Cineol zur entzündungshemmenden Behandlung von steroidpflichtigem Asthma bronchiale
DE69424181T2 (de) 1993-12-20 2000-10-19 Minnesota Mining And Mfg. Co., Saint Paul Flunisolide aerosolformulierungen
EA000889B1 (ru) * 1995-04-14 2000-06-26 Глаксо Веллкам Инк. Дозирующий ингалятор дипропионата беклометазона
GB9615394D0 (en) 1996-07-23 1996-09-04 Rolls Royce Plc Gas turbine engine rotor disc with cooling fluid passage
US20080213248A1 (en) 2004-09-02 2008-09-04 University Of Florida Research Foundation, Inc. Methods and Systems for Treating Asthma and Other Respiratory Diseases
GB0524959D0 (en) 2005-12-07 2006-01-18 Pharmakodex Ltd Topical compositions for treatment of respiratory disorders
WO2008025560A1 (en) 2006-09-01 2008-03-06 Pari Pharma Gmbh Methods for taste masking of nebulised compositions for nasal and pulmonary inhalation therapy

Also Published As

Publication number Publication date
EA022312B1 (ru) 2015-12-30
US20180153851A1 (en) 2018-06-07
US11123323B2 (en) 2021-09-21
WO2010025821A1 (de) 2010-03-11
EP2647372A1 (de) 2013-10-09
EA201170405A1 (ru) 2011-10-31
DE202009010937U1 (de) 2010-02-11
US11135194B2 (en) 2021-10-05
US20160338990A1 (en) 2016-11-24
EP2320878A1 (de) 2011-05-18
SI2320878T1 (sl) 2015-05-29
US20110257138A1 (en) 2011-10-20
EP2320878B1 (de) 2015-02-25
DE102009037359A1 (de) 2010-06-17

Similar Documents

Publication Publication Date Title
FIC20240036I1 (fi) Geeniterapia, joka ilmentää ihmisen hyytymistekijä IX:n muunnosta R338L
LTC2340031I2 (lt) Gdf gaudyklės, skirtos naudoti anemijos gydymui
BRPI0917567A2 (pt) tratamento de doença respiratória
IT1391555B1 (it) Apparato trattamento extracorporeo sangue
HUE050319T2 (hu) Kompozíciók és eljárások alkoholfogyasztással kapcsolatos rendellenességek, fájdalom és más betegségek kezelésére
BRPI0908026A2 (pt) Métodos para o tratamento de doenças do intestino
EP2320045A4 (en) APPARATUS FOR TREATING EXHAUST GAS
HUE036780T2 (hu) Új kompozíciók és eljárások immunológiai vonatkozású betegségek kezelésére
BR112012004546A2 (pt) "terapêutica por proteínas ligantes dll4-ligantes"
BRPI0916931A2 (pt) agentes terapêuticos
BRPI0910854A2 (pt) métodos de tratamento
BRPI0906606A2 (pt) Tratamento terapêutico para condições do pulmão.
DK2326374T3 (da) Inhalator
LT2451482T (lt) Kombinuota terapija, skirta diabeto gydymui
PT2236149E (pt) Composição medicinal para o tratamento de doenças infeciosas respiratórias
BRPI0909818A2 (pt) métodos, formas de dosagem e conjunto para administrar ziprasidona sem alimentos
DK2173831T3 (da) Brøndbehandling
EP3381471C0 (en) PAIN TREATMENT
LTPA2020511I1 (lt) Ciklezonidas, skirtas arklių kvėpavimo takų ligų gydymui
PL2320878T3 (pl) Monoterpeny do leczenia chorób dróg oddechowych, w szczególności chorób oskrzelowo-płucnych
BRPI0924107A2 (pt) inibidores de hsp90 para tratamento terapêutico
PL2293805T3 (pl) Kompozycja do ssania, do leczenia chorób zapalnych jamy ustnej i gardłowej
BRPI0907723A2 (pt) Métodos e composições para o tratamento de doença respiratória
EP2334304A4 (en) THERAPEUTIC BONE GROWTH AND BONE REGENERATION
PL2330892T3 (pl) Sposoby leczenia z zastosowaniem leków wychwytujących amoniak